Theregen, Inc. is a regenerative medicine company that is developing cell-based therapies
for cardiovascular indications. Anginera™, Theregen's lead product, is an epicardial patch designed to address ischemia and induce arteriogenesis in patients.

What's new?

Anginera Patch Used as Foundation for Beating Heart Cell Patch (pdf)
Theregen News Release - 07/30/09

Researchers Create Beating Heart Cells Patch;
Anginera Used as Foundation

NPR - ScienceFriday 07/24/09

Progress in Tissue Engineering (4.7 MB pdf)
Scientific American 05/09